EUVIMEDEUVIMED entdecken
Leserbrief

Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction

Ming Li, Li Xu

Cardiovascular Drugs and Therapy · 2024-12 · 38 (6) · 1187-1188

DOI: 10.1007/s10557-024-07607-8 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 15.07.2024. Verfasst von Ming Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, 252000, PR China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, 252000, PR China.
  • The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, PR China. xuli199102@163.com.

Zitieren

APA

Li, M., & Xu, L. (2024). Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction. Cardiovascular Drugs and Therapy, 38(6), 1187-1188. https://doi.org/10.1007/s10557-024-07607-8

Vancouver

Li M, Xu L. Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction. Cardiovascular Drugs and Therapy. 2024;38(6):1187-1188. doi:10.1007/s10557-024-07607-8

BibTeX
@article{Li2024,
  author = {Li, Ming and Xu, Li},
  title = {Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2024},
  volume = {38},
  number = {6},
  pages = {1187--1188},
  doi = {10.1007/s10557-024-07607-8}
}
Kostenlos starten →